|
US4034075A
(en)
|
1972-07-03 |
1977-07-05 |
Allen & Hanburys Limited |
Quinaldic acid derivatives
|
|
US6861424B2
(en)
|
2001-06-06 |
2005-03-01 |
Schering Aktiengesellschaft |
Platelet adenosine diphosphate receptor antagonists
|
|
WO2005019177A1
(en)
|
2003-08-14 |
2005-03-03 |
Icos Corporation |
Aminopiperidine amide derivatives as vla-1 integrin antagonists and uses thereof
|
|
US8278313B2
(en)
|
2008-03-11 |
2012-10-02 |
Abbott Laboratories |
Macrocyclic spiro pyrimidine derivatives
|
|
WO2010064705A1
(ja)
|
2008-12-05 |
2010-06-10 |
大日本住友製薬株式会社 |
H4受容体アンタゴニスト作用を有する新規7位置換ジヒドロピラノピリミジン誘導体
|
|
US20100331305A1
(en)
|
2009-06-24 |
2010-12-30 |
Genentech, Inc. |
Oxo-heterocycle fused pyrimidine compounds, compositions and methods of use
|
|
AR090037A1
(es)
|
2011-11-15 |
2014-10-15 |
Xention Ltd |
Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
|
|
HUE039713T2
(hu)
|
2012-06-08 |
2019-02-28 |
Sensorion |
H4 receptor inhibitorok tinnitus kezelésére
|
|
JP2014111559A
(ja)
*
|
2012-07-04 |
2014-06-19 |
Nissan Chem Ind Ltd |
ピラゾール誘導体および有害生物防除剤
|
|
CN105189505B
(zh)
|
2012-09-12 |
2019-03-22 |
默克夏普&多梅有限公司 |
用作抗菌剂的三环促旋酶抑制剂
|
|
WO2014164543A1
(en)
|
2013-03-13 |
2014-10-09 |
The Regents Of The University Of Michigan |
Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof
|
|
US9227978B2
(en)
|
2013-03-15 |
2016-01-05 |
Araxes Pharma Llc |
Covalent inhibitors of Kras G12C
|
|
CA2904393A1
(en)
|
2013-03-15 |
2014-09-25 |
Araxes Pharma Llc |
Covalent inhibitors of kras g12c
|
|
US9745319B2
(en)
|
2013-03-15 |
2017-08-29 |
Araxes Pharma Llc |
Irreversible covalent inhibitors of the GTPase K-Ras G12C
|
|
DK2981963T3
(en)
|
2013-04-05 |
2017-02-27 |
Dolby Laboratories Licensing Corp |
COMPRESSION APPARATUS AND PROCEDURE TO REDUCE QUANTIZATION NOISE USING ADVANCED SPECTRAL EXTENSION
|
|
JO3805B1
(ar)
|
2013-10-10 |
2021-01-31 |
Araxes Pharma Llc |
مثبطات كراس جي12سي
|
|
EP3055290B1
(en)
|
2013-10-10 |
2019-10-02 |
Araxes Pharma LLC |
Inhibitors of kras g12c
|
|
US20160318866A1
(en)
|
2013-12-19 |
2016-11-03 |
Bayer Pharma Aktiengesellschaft |
Substituted bipiperidinyl derivatives
|
|
JO3556B1
(ar)
|
2014-09-18 |
2020-07-05 |
Araxes Pharma Llc |
علاجات مدمجة لمعالجة السرطان
|
|
JP2017528498A
(ja)
*
|
2014-09-25 |
2017-09-28 |
アラクセス ファーマ エルエルシー |
Kras g12c変異体タンパク質のインヒビター
|
|
WO2016049565A1
(en)
|
2014-09-25 |
2016-03-31 |
Araxes Pharma Llc |
Compositions and methods for inhibition of ras
|
|
WO2016049568A1
(en)
|
2014-09-25 |
2016-03-31 |
Araxes Pharma Llc |
Methods and compositions for inhibition of ras
|
|
AU2016229294B2
(en)
|
2015-03-06 |
2021-11-04 |
Beyondspring Pharmaceuticals, Inc. |
Method of treating cancer associated with a RAS mutation
|
|
ES2898765T3
(es)
|
2015-04-10 |
2022-03-08 |
Araxes Pharma Llc |
Compuestos de quinazolina sustituidos y métodos de uso de los mismos
|
|
US10428064B2
(en)
|
2015-04-15 |
2019-10-01 |
Araxes Pharma Llc |
Fused-tricyclic inhibitors of KRAS and methods of use thereof
|
|
US10144724B2
(en)
|
2015-07-22 |
2018-12-04 |
Araxes Pharma Llc |
Substituted quinazoline compounds and methods of use thereof
|
|
WO2017015562A1
(en)
|
2015-07-22 |
2017-01-26 |
Araxes Pharma Llc |
Substituted quinazoline compounds and their use as inhibitors of g12c mutant kras, hras and/or nras proteins
|
|
EP3356349A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
|
EP3356347A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
|
EP3356351A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
|
WO2017058902A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
|
WO2017058805A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
|
WO2017058728A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
|
EP3356359B1
(en)
|
2015-09-28 |
2021-10-20 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
|
WO2017070256A2
(en)
|
2015-10-19 |
2017-04-27 |
Araxes Pharma Llc |
Method for screening inhibitors of ras
|
|
KR20180081596A
(ko)
|
2015-11-16 |
2018-07-16 |
아락세스 파마 엘엘씨 |
치환된 헤테로사이클릭 그룹을 포함하는 2-치환된 퀴나졸린 화합물 및 이의 사용 방법
|
|
US9988357B2
(en)
|
2015-12-09 |
2018-06-05 |
Araxes Pharma Llc |
Methods for preparation of quinazoline derivatives
|
|
WO2017172979A1
(en)
|
2016-03-30 |
2017-10-05 |
Araxes Pharma Llc |
Substituted quinazoline compounds and methods of use
|
|
KR102444509B1
(ko)
|
2016-05-18 |
2022-09-19 |
미라티 테라퓨틱스, 인크. |
Kras g12c 억제제
|
|
WO2018022897A1
(en)
|
2016-07-27 |
2018-02-01 |
Padlock Therapeutics, Inc. |
Covalent inhibitors of pad4
|
|
WO2018064510A1
(en)
|
2016-09-29 |
2018-04-05 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
|
EP3523289A1
(en)
|
2016-10-07 |
2019-08-14 |
Araxes Pharma LLC |
Heterocyclic compounds as inhibitors of ras and methods of use thereof
|
|
EP3538523B1
(en)
*
|
2016-11-08 |
2021-05-19 |
Cancer Research Technology Limited |
Pyrimidinone derivatives as cdc7 inhibitors
|
|
CN110366550A
(zh)
|
2016-12-22 |
2019-10-22 |
美国安进公司 |
作为用于治疗肺癌、胰腺癌或结直肠癌的KRAS G12C抑制剂的苯并异噻唑、异噻唑并[3,4-b]吡啶、喹唑啉、酞嗪、吡啶并[2,3-d]哒嗪和吡啶并[2,3-d]嘧啶衍生物
|
|
WO2018140513A1
(en)
|
2017-01-26 |
2018-08-02 |
Araxes Pharma Llc |
1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1yl)prop-2-en-1-one derivatives and similar compounds as kras g12c modulators for treating cancer
|
|
EP3573966A1
(en)
|
2017-01-26 |
2019-12-04 |
Araxes Pharma LLC |
Fused n-heterocyclic compounds and methods of use thereof
|
|
EP3573954A1
(en)
|
2017-01-26 |
2019-12-04 |
Araxes Pharma LLC |
Fused bicyclic benzoheteroaromatic compounds and methods of use thereof
|
|
US11136308B2
(en)
|
2017-01-26 |
2021-10-05 |
Araxes Pharma Llc |
Substituted quinazoline and quinazolinone compounds and methods of use thereof
|
|
JP7327802B2
(ja)
|
2017-01-26 |
2023-08-16 |
アラクセス ファーマ エルエルシー |
縮合ヘテロ-ヘテロ二環式化合物およびその使用方法
|
|
WO2018140599A1
(en)
|
2017-01-26 |
2018-08-02 |
Araxes Pharma Llc |
Benzothiophene and benzothiazole compounds and methods of use thereof
|
|
JOP20190186A1
(ar)
|
2017-02-02 |
2019-08-01 |
Astellas Pharma Inc |
مركب كينازولين
|
|
EP3621968A1
(en)
|
2017-05-11 |
2020-03-18 |
Astrazeneca AB |
Heteroaryl compounds that inhibit g12c mutant ras proteins
|
|
AU2018273356B2
(en)
|
2017-05-22 |
2021-09-16 |
Amgen Inc. |
KRAS G12C inhibitors and methods of using the same
|
|
US10745385B2
(en)
|
2017-05-25 |
2020-08-18 |
Araxes Pharma Llc |
Covalent inhibitors of KRAS
|
|
CN110869357A
(zh)
|
2017-05-25 |
2020-03-06 |
亚瑞克西斯制药公司 |
化合物及其用于治疗癌症的使用方法
|
|
WO2018218069A1
(en)
|
2017-05-25 |
2018-11-29 |
Araxes Pharma Llc |
Quinazoline derivatives as modulators of mutant kras, hras or nras
|
|
CN107556289A
(zh)
|
2017-06-22 |
2018-01-09 |
天津国际生物医药联合研究院 |
一种氯苯‑吡啶类化合物及其应用
|
|
AU2018329920B2
(en)
|
2017-09-08 |
2022-12-01 |
Amgen Inc. |
Inhibitors of KRAS G12C and methods of using the same
|
|
RU2764243C2
(ru)
|
2017-09-22 |
2022-01-14 |
ДЖУБИЛАНТ ЭПИПЭД ЭлЭлСи |
Гетероциклические соединения в качестве ингибиторов PAD
|
|
GB201715342D0
(en)
|
2017-09-22 |
2017-11-08 |
Univ Nottingham |
Compounds
|
|
CN109670389B
(zh)
|
2017-10-16 |
2023-04-07 |
富士通株式会社 |
评价人脸图像中的光照条件的方法和设备
|
|
AU2018352142B2
(en)
|
2017-10-18 |
2022-08-25 |
Jubilant Epipad LLC |
Imidazo-pyridine compounds as PAD inhibitors
|
|
US10647715B2
(en)
|
2017-11-15 |
2020-05-12 |
Mirati Therapeutics, Inc. |
KRas G12C inhibitors
|
|
LT3710439T
(lt)
|
2017-11-15 |
2023-05-10 |
Mirati Therapeutics, Inc. |
Kras g12c inhibitoriai
|
|
WO2019099703A1
(en)
|
2017-11-16 |
2019-05-23 |
Sidecar Therapeutics, Inc. |
Apoptosis signal-regulating kinase 1 (ask 1) inhibitor compounds
|
|
US10597405B2
(en)
|
2017-12-08 |
2020-03-24 |
Astrazeneca Ab |
Chemical compounds
|
|
TW201942116A
(zh)
|
2018-02-09 |
2019-11-01 |
美商輝瑞股份有限公司 |
作為抗癌劑之四氫喹唑啉衍生物
|
|
IL276232B2
(en)
|
2018-03-02 |
2024-04-01 |
Otsuka Pharma Co Ltd |
Pyrazine derivatives, pharmaceutical compositions comprising them and their use for treating diseases
|
|
WO2019185525A1
(en)
|
2018-03-28 |
2019-10-03 |
Bayer Pharma Aktiengesellschaft |
4-(3-amino-6-fluoro-1h-indazol-5-yl)-1,2,6-trimethyl-1,4-dihydropyridine-3,5-dic arbonitrile compounds for treating hyperproliferative disorders
|
|
CA3098574A1
(en)
|
2018-05-04 |
2019-11-07 |
Amgen Inc. |
Kras g12c inhibitors and methods of using the same
|
|
TW202012415A
(zh)
|
2018-05-08 |
2020-04-01 |
瑞典商阿斯特捷利康公司 |
化學化合物
|
|
US11285156B2
(en)
|
2018-06-12 |
2022-03-29 |
Amgen Inc. |
Substituted piperazines as KRAS G12C inhibitors
|
|
AU2019320945C1
(en)
|
2018-08-16 |
2021-09-30 |
F. Hoffmann-La Roche Ag |
Fused ring compounds
|
|
JP6648797B2
(ja)
|
2018-10-04 |
2020-02-14 |
株式会社三洋物産 |
遊技機
|
|
TW202033518A
(zh)
|
2018-10-15 |
2020-09-16 |
美商美國禮來大藥廠 |
Kras g12c 抑制劑
|
|
WO2020085504A1
(ja)
|
2018-10-26 |
2020-04-30 |
大鵬薬品工業株式会社 |
光照射ザンドマイヤー反応を用いたクロロアゾールカルボキシレート誘導体の製造方法
|
|
PE20260440A1
(es)
|
2018-11-09 |
2026-02-19 |
Hoffmann La Roche |
Compuestos de anillo fusionado
|
|
AU2019384118B2
(en)
|
2018-11-19 |
2025-06-12 |
Amgen Inc. |
KRAS G12C inhibitors and methods of using the same
|
|
EP3887373A1
(en)
|
2018-11-29 |
2021-10-06 |
Araxes Pharma LLC |
Compounds and methods of use thereof for treatment of cancer
|
|
EP3908283A4
(en)
|
2019-01-10 |
2022-10-12 |
Mirati Therapeutics, Inc. |
KRAS G12C INHIBITORS
|
|
EP3919483A4
(en)
|
2019-01-29 |
2022-02-09 |
Brightgene Bio-medical Technology Co., Ltd. |
HETEROCYCLIC BENZOPYRIDONE COMPOUND AND USE THEREOF
|
|
WO2020177629A1
(zh)
|
2019-03-01 |
2020-09-10 |
劲方医药科技(上海)有限公司 |
螺环取代的嘧啶并环类化合物,其制法与医药上的用途
|
|
KR102934231B1
(ko)
|
2019-03-05 |
2026-03-06 |
아스트라제네카 아베 |
항암제로 유용한 융합 삼환식 화합물
|
|
KR20220012255A
(ko)
|
2019-04-28 |
2022-02-03 |
젠플리트 테라퓨틱스 (상하이) 아이엔씨. |
옥사아자퀴나졸린-7(8h)-케톤 화합물, 이의 제조 방법 및 이의 약학적 응용
|
|
JP7502337B2
(ja)
|
2019-05-20 |
2024-06-18 |
カリフォルニア インスティチュート オブ テクノロジー |
Kras g12cインヒビター及びその使用
|
|
WO2020234103A1
(en)
|
2019-05-21 |
2020-11-26 |
Bayer Aktiengesellschaft |
Identification and use of kras inhibitors
|
|
CN114437065A
(zh)
|
2019-05-21 |
2022-05-06 |
益方生物科技(上海)股份有限公司 |
杂环化合物,其制备方法和用途
|
|
TW202110837A
(zh)
|
2019-05-24 |
2021-03-16 |
大陸商江蘇恆瑞醫藥股份有限公司 |
氫化吡啶并嘧啶類衍生物、其製備方法及其在醫藥上的應用
|
|
WO2020239077A1
(zh)
|
2019-05-29 |
2020-12-03 |
上海翰森生物医药科技有限公司 |
含氮杂环类衍生物调节剂、其制备方法和应用
|
|
CN113396147B
(zh)
|
2019-05-31 |
2024-06-18 |
上海翰森生物医药科技有限公司 |
芳香杂环类衍生物调节剂、其制备方法和应用
|
|
PH12021553058A1
(en)
|
2019-06-06 |
2022-07-25 |
Hutchison Medipharma Ltd |
Tricyclic compounds and their use
|
|
AU2020308353B9
(en)
|
2019-06-24 |
2024-01-25 |
Guangdong Newopp Biopharmaceuticals Co., Ltd. |
Heterocyclic compounds as inhibitors of KRAS G12C
|
|
US12421236B2
(en)
|
2019-06-25 |
2025-09-23 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor
|
|
CN110256421A
(zh)
|
2019-06-26 |
2019-09-20 |
微境生物医药科技(上海)有限公司 |
Kras-g12c抑制剂
|
|
WO2021000885A1
(zh)
|
2019-07-01 |
2021-01-07 |
江苏恒瑞医药股份有限公司 |
喹唑啉酮类衍生物、其制备方法及其在医药上的应用
|
|
JP7756069B6
(ja)
|
2019-08-02 |
2025-11-27 |
上海済▲ユウ▼医薬科技股▲フン▼有限公司 |
四環式化合物、その調製と使用の方法
|
|
CN112341457A
(zh)
|
2019-08-07 |
2021-02-09 |
北京加科思新药研发有限公司 |
Kras突变蛋白抑制剂
|
|
CN114174298B
(zh)
|
2019-08-14 |
2023-08-01 |
正大天晴药业集团南京顺欣制药有限公司 |
哒嗪酮并嘧啶类衍生物及其医药用途
|
|
CN112390797A
(zh)
|
2019-08-15 |
2021-02-23 |
微境生物医药科技(上海)有限公司 |
新型螺环类K-Ras G12C抑制剂
|
|
WO2021031952A1
(zh)
|
2019-08-16 |
2021-02-25 |
劲方医药科技(上海)有限公司 |
氧代六元环并嘧啶类化合物,其制法与医药上的用途
|
|
CN114269735B
(zh)
|
2019-08-26 |
2024-02-23 |
南京创济生物医药有限公司 |
二氢或四氢喹唑啉类化合物及其中间体、制备方法和应用
|
|
CN112430234B
(zh)
|
2019-08-26 |
2023-04-28 |
信达生物制药(苏州)有限公司 |
一种新型kras g12c蛋白抑制剂及其制备方法和用途
|
|
MX2022002465A
(es)
|
2019-08-29 |
2022-05-19 |
Mirati Therapeutics Inc |
Inhibidores de kras g12d.
|
|
WO2021043322A1
(zh)
|
2019-09-06 |
2021-03-11 |
正大天晴药业集团南京顺欣制药有限公司 |
氮杂环庚烷并嘧啶类衍生物及其医药用途
|
|
US20220402916A1
(en)
|
2019-09-18 |
2022-12-22 |
Merck Sharp & Dohme Corp. |
Small molecule inhibitors of kras g12c mutant
|
|
WO2021052499A1
(zh)
|
2019-09-20 |
2021-03-25 |
上海济煜医药科技有限公司 |
稠合吡啶酮类化合物及其制备方法和应用
|
|
TW202115062A
(zh)
|
2019-09-25 |
2021-04-16 |
大陸商北京加科思新藥研發有限公司 |
Kras突變蛋白抑制劑
|
|
WO2021058018A1
(en)
|
2019-09-29 |
2021-04-01 |
Beigene, Ltd. |
Inhibitors of kras g12c
|
|
WO2021063346A1
(zh)
|
2019-09-30 |
2021-04-08 |
上海迪诺医药科技有限公司 |
Kras g12c抑制剂及其应用
|
|
CN112694475B
(zh)
|
2019-10-23 |
2025-09-23 |
苏州泽璟生物制药股份有限公司 |
环烷基类和杂环烷基类抑制剂及其制备方法和应用
|
|
EP4048671B1
(en)
|
2019-10-24 |
2026-03-18 |
Amgen Inc. |
Pyridopyrimidine derivatives useful as kras g12c and kras g12d inhibitors in the treatment of cancer
|
|
UA129778C2
(uk)
|
2019-10-28 |
2025-07-30 |
Мерк Шарп Енд Доум Елелсі |
Низькомолекулярні інгібітори g12c-мутантного kras
|
|
CN114585610A
(zh)
|
2019-10-28 |
2022-06-03 |
日本曹达株式会社 |
2,6-二氧代-3,6-二氢嘧啶化合物以及农业园艺用杀菌剂、杀线虫剂、及医疗用·动物用抗真菌剂
|
|
JP7601869B2
(ja)
|
2019-10-30 |
2024-12-17 |
▲勁▼方医▲薬▼科技(上海)有限公司 |
置換された複素環-環系化合物、その調製方法及び医薬への応用
|
|
WO2021084765A1
(en)
|
2019-10-31 |
2021-05-06 |
Taiho Pharmaceutical Co., Ltd |
4-aminobut-2-enamide derivatives and salts thereof
|
|
US20230023023A1
(en)
|
2019-10-31 |
2023-01-26 |
Taiho Pharmaceutical Co., Ltd. |
4-aminobut-2-enamide derivatives and salts thereof
|
|
CN113286794B
(zh)
|
2019-11-04 |
2024-03-12 |
北京加科思新药研发有限公司 |
Kras突变蛋白抑制剂
|
|
CN114630832A
(zh)
|
2019-11-15 |
2022-06-14 |
四川海思科制药有限公司 |
一种嘧啶并环衍生物及其在医药上的应用
|
|
CN112824410A
(zh)
|
2019-11-21 |
2021-05-21 |
苏州泽璟生物制药股份有限公司 |
氮杂七元环类抑制剂及其制备方法和应用
|
|
CN113614080B
(zh)
|
2019-11-29 |
2022-06-28 |
苏州信诺维医药科技股份有限公司 |
Kras g12c抑制剂化合物及其用途
|
|
WO2021106231A1
(en)
|
2019-11-29 |
2021-06-03 |
Taiho Pharmaceutical Co., Ltd. |
A compound having inhibitory activity against kras g12d mutation
|
|
EP4067343A4
(en)
|
2019-11-29 |
2024-01-03 |
Taiho Pharmaceutical Co., Ltd. |
NEW PHENOLIC COMPOUND OR SALT THEREOF
|
|
WO2021109737A1
(zh)
|
2019-12-02 |
2021-06-10 |
上海璎黎药业有限公司 |
一种含氧杂环化合物、其制备方法及应用
|
|
WO2021113595A1
(en)
|
2019-12-06 |
2021-06-10 |
Beta Pharma, Inc. |
Phosphorus derivatives as kras inhibitors
|
|
PT3886991T
(pt)
|
2019-12-11 |
2022-10-17 |
Lilly Co Eli |
Inibidores de kras g12c
|
|
WO2021120045A1
(en)
|
2019-12-18 |
2021-06-24 |
InventisBio Co., Ltd. |
Heterocyclic compounds, preparation methods and uses thereof
|
|
CN114761408B
(zh)
|
2019-12-19 |
2023-09-15 |
贝达药业股份有限公司 |
Kras g12c抑制剂及其在医药上的应用
|
|
IL293962B2
(en)
|
2019-12-19 |
2025-10-01 |
Jacobio Pharmaceuticals Co Ltd |
Mutant KRAS protein inhibitors
|
|
CA3164995A1
(en)
|
2019-12-20 |
2021-06-24 |
Erasca, Inc. |
Tricyclic pyridones and pyrimidones
|
|
WO2021120890A1
(en)
|
2019-12-20 |
2021-06-24 |
Novartis Ag |
Pyrazolyl derivatives useful as anti-cancer agents
|
|
CN113045565A
(zh)
|
2019-12-27 |
2021-06-29 |
微境生物医药科技(上海)有限公司 |
新型K-Ras G12C抑制剂
|
|
CN115003668A
(zh)
|
2020-01-21 |
2022-09-02 |
南京明德新药研发有限公司 |
作为kras抑制剂的大环类化合物
|
|
WO2021215544A1
(en)
|
2020-04-24 |
2021-10-28 |
Taiho Pharmaceutical Co., Ltd. |
Kras g12d protein inhibitors
|
|
WO2021215545A1
(en)
|
2020-04-24 |
2021-10-28 |
Taiho Pharmaceutical Co., Ltd. |
Anticancer combination therapy with n-(1-acryloyl-azetidin-3-yl)-2-((1h-indazol-3-yl)amino)methyl)-1h-imidazole-5-carboxamide inhibitor of kras-g12c
|
|
WO2021219072A1
(zh)
|
2020-04-30 |
2021-11-04 |
上海科州药物研发有限公司 |
作为kras抑制剂的杂环化合物的制备及其应用方法
|
|
US20230357277A1
(en)
|
2020-09-22 |
2023-11-09 |
Mirati Therapeutics, Inc. |
Kras g12d inhibitors
|
|
EP4247807A4
(en)
|
2020-11-23 |
2024-10-16 |
Merck Sharp & Dohme LLC |
6,7-DIHYDRO-PYRANO[2,3-D PYRIMIDINE AS INHIBITORS OF THE KRAS G12C MUTANT
|
|
US20240124478A1
(en)
|
2020-11-23 |
2024-04-18 |
Merck Sharp & Dohme Llc |
SPIROCYCLIC-SUBSTITUTED 6,7-DIHYDRO-PYRANO[2,3-d]PYRIMIDINE INHIBITORS OF KRAS G12C MUTANT
|
|
JP2023553492A
(ja)
|
2020-12-15 |
2023-12-21 |
ミラティ セラピューティクス, インコーポレイテッド |
アザキナゾリン汎KRas阻害剤
|
|
EP4262803A4
(en)
|
2020-12-16 |
2025-03-12 |
Mirati Therapeutics, Inc. |
Tetrahydropyridopyrimidine pan-kras inhibitors
|
|
EP4291199A4
(en)
|
2021-02-09 |
2025-06-18 |
Kumquat Biosciences Inc. |
Heterocyclic compounds and uses thereof
|
|
BR112023016299A2
(pt)
|
2021-02-16 |
2023-11-28 |
L Livermore Nat Security Llc |
Composições e métodos para inibir kras
|
|
EP4322954A4
(en)
|
2021-04-16 |
2025-01-29 |
Merck Sharp & Dohme LLC |
SMALL MOLECULAR INHIBITORS OF THE KRAS G12D MUTANT
|
|
US20240262842A1
(en)
|
2021-04-27 |
2024-08-08 |
Merck Sharp & Dohme Llc |
Small molecule inhibitors of kras g12c mutant
|
|
US20240246968A1
(en)
|
2021-04-27 |
2024-07-25 |
Merck Sharp & Dohme Llc |
Small molecule inhibitors of kras g12c mutant
|
|
EP4347606A4
(en)
|
2021-05-28 |
2025-04-02 |
Merck Sharp & Dohme LLC |
SMALL MOLECULES INHIBITING THE G12C KRAS MUTANT
|
|
EP4347041A1
(en)
|
2021-05-28 |
2024-04-10 |
Taiho Pharmaceutical Co., Ltd. |
Small molecule inhibitors of kras mutated proteins
|
|
WO2022256459A1
(en)
|
2021-06-01 |
2022-12-08 |
Quanta Therapeutics, Inc. |
Kras modulators and uses thereof
|
|
EP4436571A4
(en)
|
2021-11-24 |
2025-10-15 |
Merck Sharp & Dohme Llc |
SMALL MOLECULE INHIBITORS OF KRAS MUTATIONAL PROTEINS
|
|
US20260083750A1
(en)
|
2022-08-26 |
2026-03-26 |
Merck Sharp & Dohme Llc |
Small molecule inhibitors of kras proteins
|